Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM
Clinical trial NCT06255847 · UNKNOWN
Trial details
- NCT number
- NCT06255847
- Sponsor
- Shanxi Bethune Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-15
- Primary completion
- 2025-06-15
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.